[ad_1]
Source: Dubai – Arabic.net
French President Emmanuel Macron considered that the possible vaccine for the Covid-19 epidemic should not be subject to “market laws”, after the drug group Sanofi announced that it would give priority to the United States if it developed a vaccine. successfully announced the French presidency on Thursday.
Elysee said “efforts made in recent months show that this vaccine needs to be a global public good and not subject to market law,” explaining that the French president will meet with Sanofi officials in early next week.
Sanofi CEO Paul Hudson had sparked a storm in France that upheld his statement that Americans would have priority in getting a vaccine the company was developing because they had invested financially to support their research.
Olivier Bugelo, the company’s president in France, was quick to clarify what the CEO said. He assured that the countries of the European Union would receive the vaccine upon reaching it, provided that it demonstrates the same effectiveness in supporting the financing of the manufacture of the vaccine.
In addition, the French Pasteur Institute is working on three projects to develop a vaccine against the Covid-19 epidemic, the most advanced version of which is based on a modified measles vaccine, the first results of which are expected to appear in October, according to Christian Christian. , coordinator of the vaccination program.
“We hope to obtain the necessary green light to launch clinical trials in July, and trials will begin immediately after obtaining this approval,” said Christian Gerak, coordinator of the institute’s vaccine-related program.
The pastor’s institute
He added: “The first results of the first stage are expected to be published in late October. The second stage or the second and third stages are scheduled for early December.”
“Once enough information has been gathered about the quality, safety, efficacy and immunity of the vaccine, an urgent request can be made for use by the World Health Organization,” he added.
There are more than 100 vaccine projects with the Covid-19 vaccine, of which about a dozen have reached clinical trials.
[ad_2]
